GB0511019D0 - Drug fusions and conjugates - Google Patents
Drug fusions and conjugatesInfo
- Publication number
- GB0511019D0 GB0511019D0 GB0511019A GB0511019A GB0511019D0 GB 0511019 D0 GB0511019 D0 GB 0511019D0 GB 0511019 A GB0511019 A GB 0511019A GB 0511019 A GB0511019 A GB 0511019A GB 0511019 D0 GB0511019 D0 GB 0511019D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- conjugates
- drug fusions
- fusions
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0511019A GB0511019D0 (en) | 2005-05-31 | 2005-05-31 | Drug fusions and conjugates |
SG200907919-5A SG157423A1 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
CA002589800A CA2589800A1 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
US11/791,930 US20090214534A1 (en) | 2004-12-02 | 2005-11-30 | Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY |
KR1020077015211A KR20070094909A (en) | 2004-12-02 | 2005-11-30 | Bispecific domain ant1bodies targeting serum albumin and glp-1 or pyy |
NZ555464A NZ555464A (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
RU2007119990/10A RU2428431C2 (en) | 2004-12-02 | 2005-11-30 | Fused drug constructs and conjugates |
PCT/GB2005/004599 WO2006059106A2 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
AU2005311099A AU2005311099B2 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
CN2005800476479A CN101128487B (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
BRPI0518761-3A BRPI0518761A2 (en) | 2004-12-02 | 2005-11-30 | drug fusion, drug conjugate, Recombinant Nucleic Acid, Nucleic Acid Construction, Host Cell, Method for Producing a Drug Fusion, Pharmaceutical Composition, Drug, Method of Treatment and / or Prevention of a Condition in a Patient, Delay Method or prevention of disease progression, and a method for decreasing food absorption by a patient |
JP2007543909A JP5185624B2 (en) | 2004-12-02 | 2005-11-30 | Bispecific antibodies targeting serum albumin and GLP-1 or PYY |
EP20050810713 EP1841796A2 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
EP13163377.8A EP2769990A3 (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
MX2007006605A MX2007006605A (en) | 2004-12-02 | 2005-11-30 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy. |
IL183450A IL183450A0 (en) | 2004-12-02 | 2007-05-28 | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
NO20072751A NO20072751L (en) | 2004-12-02 | 2007-05-30 | Bispecific domain antibodies targeted against serum albumin and GLP-1 or PYY |
MA29951A MA29079B1 (en) | 2004-12-02 | 2007-05-30 | MERGERS AND MEDICINAL CONJUGATES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0511019A GB0511019D0 (en) | 2005-05-31 | 2005-05-31 | Drug fusions and conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0511019D0 true GB0511019D0 (en) | 2005-07-06 |
Family
ID=34834862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0511019A Ceased GB0511019D0 (en) | 2004-12-02 | 2005-05-31 | Drug fusions and conjugates |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0511019D0 (en) |
-
2005
- 2005-05-31 GB GB0511019A patent/GB0511019D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246200A1 (en) | Beta-glucuronide drug linker conjugates | |
IL179633A0 (en) | Drug compositions, fusions and conjugates | |
HK1117410A1 (en) | Antibody-drug conjugates and their use | |
ZA201006763B (en) | Drug fusions and conjugates | |
IL186521A0 (en) | Nanoparticle-active ingredient conjugates | |
EP1781689A4 (en) | Conjugates and therapeutic uses thereof | |
IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
IL180762A (en) | Insulin-oligomer conjugates and formulations and uses thereof | |
PL1877073T3 (en) | Non-cytotoxic protein conjugates | |
IL179077A0 (en) | Chemical linkers and conjugates thereof | |
SI1957073T1 (en) | Medicinal drug | |
EP1718335A4 (en) | Drug conjugates | |
AP2008004533A0 (en) | Pharmaceutical combination | |
EP1876178A4 (en) | Cyanopyridine derivative and use thereof as medicine | |
IL176918A0 (en) | Ghrelin-carrier conjugates | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
IL187479A0 (en) | Antigen conjugates and uses thereof | |
EP1714648A4 (en) | Combination drug | |
EP1838317A4 (en) | Analgesic conjugates | |
EP2025667A4 (en) | 9,10-secopregnane derivative and pharmaceutical | |
EP1940386A4 (en) | Wortmannin conjugates and uses thereof | |
ZA200804666B (en) | Pharmaceutical combination | |
IL181228A0 (en) | Vlp-antigen conjugates and their uses as vaccines | |
TWI372053B (en) | Combination drug | |
PL1944298T3 (en) | Quinazoline derivative and pharmaceutical |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |